Page last updated: 2024-10-22

amantadine and AIDS-Related Opportunistic Infections

amantadine has been researched along with AIDS-Related Opportunistic Infections in 3 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.

Research Excerpts

ExcerptRelevanceReference
" Their adverse effects mostly involve bone marrow depression (e."2.39Adverse effects and drug interactions of clinical importance with antiviral drugs. ( Morris, DJ, 1994)
"Although annual influenza vaccination is recommended for persons who are infected with human immunodeficiency virus (HIV), data are limited regarding the epidemiology of influenza or the effectiveness of influenza vaccination in this population."1.31Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City. ( Baker, I; Bridges, CB; De Guzman, AM; Fine, AD; Fukuda, K; Glover, L; Regnery, H; Wong, SJ; Zeller, B, 2001)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morris, DJ1
Hayden, FG1
Fine, AD1
Bridges, CB1
De Guzman, AM1
Glover, L1
Zeller, B1
Wong, SJ1
Baker, I1
Regnery, H1
Fukuda, K1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 3, Randomized, Controlled, Open Label Study to Evaluate the Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Vaccines Against Novel H1N1 Virus in Patients With Human Immunodeficiency Virus Type 1 (HIV-1) Infection[NCT01032408]Phase 3154 participants (Actual)Interventional2010-04-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for amantadine and AIDS-Related Opportunistic Infections

ArticleYear
Adverse effects and drug interactions of clinical importance with antiviral drugs.
    Drug safety, 1994, Volume: 10, Issue:4

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Int

1994
Prevention and treatment of influenza in immunocompromised patients.
    The American journal of medicine, 1997, Mar-17, Volume: 102, Issue:3A

    Topics: Aerosols; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Bone Marrow Transplan

1997

Other Studies

1 other study available for amantadine and AIDS-Related Opportunistic Infections

ArticleYear
Influenza A among patients with human immunodeficiency virus: an outbreak of infection at a residential facility in New York City.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Jun-15, Volume: 32, Issue:12

    Topics: Adult; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Disease Outbreaks; Femal

2001